Fetal Monitoring, Diagnostics and Predictive Tests

Jan 2015| HLC089B| BCC Publishing

Report Highlights

The global market for fetal monitoring, prenatal diagnostics, predictive tests and neonatal monitoring was valued at roughly $8.6 billion in 2013 and about $9.0 billion in 2014. This market is expected to reach about $10.9 billion by 2019, with a compound annual growth rate (CAGR) of 4.0% from 2014 to 2019.

Report Includes

  • An overview of the global markets for fetal monitoring, diagnostics, and predictive tests.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Information on the strengths and weaknesses of each category of fetal monitoring and diagnosis in addition to new technologies and developments, manufacturer and supplier competition, and the changing environment of the market due to the increasing awareness of expectant mothers.
  • Discussion covering acquisitions, mergers, and alliances by companies and global organizations.
  • Comprehensive company profiles of major players in the industry.

SCOPE OF THE STUDY

This study is mainly focused on fetal monitoring and related markets. Therefore, it does not focus on neonatal monitoring. The study is focused on fetal diseases, fetal monitoring products, diagnostic and predictive tests. The study has listed almost all the participating companies in the fetal monitoring sector and their products relevant to this field.

ANALYST’S CREDENTIALS

This study was carried out by retired professor P. Natana Raj, who holds a master’s degree in biology. He also holds diplomas in biochemistry, biotechnology, biochemical pharmacology, environmental biology and plant embryology. He has 34 years of experience in teaching biochemistry, biotechnology, pharmacology, molecular biology and genetics. Since 2007, he has authored 26 market research reports in the health care sector.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
[+] Show Chapter Details
Title/Chapter Name Pages Price Member Price
Full Report: Fetal Monitoring, Diagnostics and Predictive Tests 266 $2,750 Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: EXECUTIVE SUMMARY3$250Free
Chapter- 3: INDICATIONS ADDRESSED BY FETAL MONITORING AND RELATED DIAGNOSTICS: AN OVERVIEW14$145Free
Chapter- 4: FETAL MONITORING TECHNOLOGIES: AN OVERVIEW29$300Free
Chapter- 5: PRENATAL DIAGNOSIS AND FETAL THERAPY28$289Free
Chapter- 6: PREDICTIVE GENETIC TESTING20$207Free
Chapter- 7: MARKET ANALYSIS23$238Free
Chapter- 8: FETAL MONITORING INDUSTRY PARTICIPANTS3$31Free
Chapter- 9: LATEST INNOVATIONS IN FETAL MONITORING SECTOR: 20142$21Free
Chapter- 10: COMPANY PROFILES141$1,458Free
Published - Apr-2011| Analyst - Shalini Shahani Dewan| Code - HLC089A

Report Highlights

The global market for fetal monitoring, diagnostics, and predictive tests reached approximately $6.2 billion in 2010.  The market is expected to rise at a compound annual growth rate (CAGR) of 4.4% and reach approximately $8 billion by 2016.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
DNA Vaccines: Technologies and Global Markets

The global market for DNA vaccines was valued at $243.7 million in 2013 and is expected to increase to $305.3 million in 2014, and further to $2.7 billion by 2019, a compound annual growth rate (CAGR) of 54.8% over the five-year period from 2014 through 2019.

Jon Evans | Jul 2014

The Global Influenza Market

The global influenza market will grow from nearly $3.8 billion in 2012 to $4 billion in 2013. Market revenue is forecast to increase at a five-year compound annual growth rate (CAGR) of 8% from 2013 to 2018, totaling nearly $6 billion in 2018.

Melissa Elder | Nov 2013

Global Markets for Media, Sera and Reagents in Biotechnology

The global market for media, sera and reagents used in biotechnology was valued at $2.3 billion in 2009, $2.5 billion in 2010 and is estimated to have reached nearly $2.8 billion at the end of 2011. The market is expected to reach $4.2 billion by 2016, a compound annual growth rate (CAGR) of 8.8%.

Shalini Shahani Dewan | Apr 2012

Organ and Tissue Transplantation and Alternatives

The global market for transplantation products, devices, and pharmaceuticals was valued at nearly $54 billion in 2010 and is projected to grow at an 8.3% compound annual growth rate (CAGR) to reach $80 billion in 2015.

Peggy Lehr | Jan 2011

Share This Report
Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

BCC Research provides objective, unbiased measurement and assessment of market opportunities with detailed market research reports. Our experienced industry analysts assess growth opportunities, market sizing, technologies, applications, supply chains and companies with the singular goal of helping you make informed business decisions, free of noise and hype.

Contact
© 2020 BCC Research
Privacy Policy |Site Map|Terms & Conditions